XML 16 R7.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Preferred Units and Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Gain (Loss) [Member]
Accumulated Deficit [Member]
Beginning balance at Dec. 31, 2020 $ 56,207 $ 10 $ 204,007 $ 0 $ (147,810)
Beginning balance, shares at Dec. 31, 2020   10,193,831      
Stock/equity-based compensation expense 1,407   1,407    
Net loss (8,682)       (8,682)
Ending balance at Mar. 31, 2021 48,932 $ 10 205,414 0 (156,492)
Ending balance, shares at Mar. 31, 2021   10,193,831      
Beginning balance at Dec. 31, 2020 56,207 $ 10 204,007 0 (147,810)
Beginning balance, shares at Dec. 31, 2020   10,193,831      
Net loss (19,136)        
Ending balance at Jun. 30, 2021 41,107 $ 10 208,043 0 (166,946)
Ending balance, shares at Jun. 30, 2021   10,282,046      
Beginning balance at Mar. 31, 2021 48,932 $ 10 205,414 0 (156,492)
Beginning balance, shares at Mar. 31, 2021   10,193,831      
Exercises of common stock options 57   57    
Exercises of common stock options, shares   6,083      
Stock/equity-based compensation expense 1,259   1,259    
Issuance of common stock, net of issuance costs, shares   82,132      
Issuance of common stock, net of issuance costs 1,313   1,313    
Net loss (10,454)       (10,454)
Ending balance at Jun. 30, 2021 41,107 $ 10 208,043 0 (166,946)
Ending balance, shares at Jun. 30, 2021   10,282,046      
Beginning balance at Dec. 31, 2021 23,497 $ 11 210,799 0 (187,313)
Beginning balance, shares at Dec. 31, 2021   10,644,714      
Vesting of restricted stock unit, shares   17,624      
Stock/equity-based compensation expense 1,204   1,204    
Forfeiture of restricted stock awards, Shares   (31,930)      
Issuance of common stock, net of issuance costs, shares   216,332      
Issuance of common stock, net of issuance costs 383   383    
Net loss (13,381)       (13,381)
Ending balance at Mar. 31, 2022 11,703 $ 11 212,386 0 (200,694)
Ending balance, shares at Mar. 31, 2022   10,846,740      
Beginning balance at Dec. 31, 2021 $ 23,497 $ 11 210,799 0 (187,313)
Beginning balance, shares at Dec. 31, 2021   10,644,714      
Exercises of common stock options, shares 0        
Net loss $ (18,226)        
Ending balance at Jun. 30, 2022 7,930 $ 11 213,458 0 (205,539)
Ending balance, shares at Jun. 30, 2022   10,842,945      
Beginning balance at Mar. 31, 2022 11,703 $ 11 212,386 0 (200,694)
Beginning balance, shares at Mar. 31, 2022   10,846,740      
Stock/equity-based compensation expense 1,072   1,072    
Forfeiture of restricted stock awards, Shares   (3,795)      
Net loss (4,845)       (4,845)
Ending balance at Jun. 30, 2022 $ 7,930 $ 11 $ 213,458 $ 0 $ (205,539)
Ending balance, shares at Jun. 30, 2022   10,842,945